Daniel Feith News Today

Oracle Solicitors Tim Fongern talks with REWAKE Co-CEO Daniel Feith about the companys move into second-hand luxury, sustainability concerns, the challenges of counterfeiting and plans for growth.

It may not alleviate the Jewish community’s heavy tuition burden, but a watershed decision like this from the Supreme Court certainly has the potential to lighten the load.

    It may not alleviate the Jewish community’s heavy tuition burden, but a watershed decision like this from the Supreme Court certainly has the potential to lighten the load.

Reply A federal court entered a permanent injunction barring a Georgia company from selling unapproved coronavirus treatments. (Shutterstock) ALPHARETTA, GA — A federal court entered a permanent injunction barring a Georgia company from selling unapproved vitamin D products touted as treatments for COVID-19, the Department of Justice said Friday. In a civil complaint and accompanying court papers filed in November 2020 in U.S. District Court for the Southern District of Georgia, the United St...

To embed, copy and paste the code into your website or blog: Following up on our colleagues’ post earlier this month covering the Food and Drug Administration’s 2020 device law and policy activities, this post will explore prescription drug and biologic law and policy developments over the past year. We’ll also begin looking forward into 2021 and the agency’s transition to an incoming Biden Administration. One of the highest priorities for the Food and Drug Administration (FDA) during t...

Tuesday, December 22, 2020 Following up on our colleagues’ post earlier this month covering the Food and Drug Administration’s 2020 device law and policy activities, this post will explore prescription drug and biologic law and policy developments over the past year. We’ll also begin looking forward into 2021 and the agency’s transition to an incoming Biden Administration. One of the highest priorities for the Food and Drug Administration (FDA) during this “pandemic year 1...

ADVERTISEMENT ADVERTISEMENT DOJ Opioid Leader Flays Pharmacies In Enforcement Vow Law360 (December 15, 2020, 10:40 PM EST) -- Many pharmacies have ignored their legal duty to prevent the diversion of narcotic painkillers for illicit uses, and related enforcement actions are likely in 2021, one of the U.S. Department of Justices top opioid attorneys said Tuesday. Daniel Feith, a deputy assistant attorney general overseeing the DOJs Consumer Protection Branch, made the comments during a keynote a...